Zymergen

Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Zymergen Inc. (NASDAQ: ZY) ("Zymergen") This lawsuit is on behalf of investors who purchased ZY common stock pursuant and/or traceable to the documents issued in connection with the Company's April 2021 initial public offering.. You are hereby notified that a securities class action lawsuit has...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - ZY

New York, New York--(Newsfile Corp. - October 3, 2021) - WHY: New York, N.Y., October 3, 2021. Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering (the "IPO"), of the important October 4, 2021 lead plaintiff deadline.SO WHAT: If you purchased...

ZY Final Deadline Tomorrow: Rosen, A Top Ranked Law Firm, Encourages Zymergen Inc. Investors with Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - ZY

Radnor, Pennsylvania--(Newsfile Corp. - October 3, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of lead plaintiff deadline in securities fraud class action lawsuit filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of those who purchased or acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering ("IPO").Deadline Reminder: ...

Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Zymergen Inc. Investors - ZY

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - October 1, 2021) -  Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and reminds investors of the October 4, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $50,000 investing in Zymergen stock or options between...

Zymergen Shareholder Alert

Boston, Massachusetts--(Newsfile Corp. - October 1, 2021) - The Thornton Law Firm alerts investors who purchased Zymergen Inc. common stock (NASDAQ: ZY) pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial public offering may seek to participate in the case as a Lead Plaintiff. Interested investors may contact the Thornton Law Firm's investor protection team by visiting www.tenlaw.com/cases/Zymergen for more information. Investors may also email...

ZY Investor Alert: Shareholder Lawsuit Deadline Approaching

New York, New York--(Newsfile Corp. - October 1, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Zymergen Inc. (NASDAQ: ZY) pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering (the "IPO"), of the important October 4, 2021 lead plaintiff deadline.SO WHAT: If you purchased Zymergen securities pursuant and/or traceable to...

ZY Final Deadline Monday: Rosen, Trusted Investor Counsel, Encourages Zymergen Inc. Investors with Losses in Excess of $100K Secure Counsel Before Important October 4 Deadline in Securities Class Action - ZY

New York, New York--(Newsfile Corp. - October 1, 2021) -  Pomerantz LLP is investigating claims on behalf of investors of Zymergen, Inc. ("Zymergen or the "Company") (NASDAQ: ZY). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.The investigation concerns whether Zymergen and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the...

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymergen, Inc. - ZY

LOS ANGELES--(BUSINESS WIRE)---- $ZY #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Zymergen Inc. (ZY)

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Zymergen Inc. (ZY)

Activision Blizzard

View

NEW YORK, NY / ACCESSWIRE / October 1, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

SHAREHOLDER ALERT: ATVI ZY VIEW: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines

NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Zymergen, Inc. ("Zymergen” or the "Company") (NASDAQ: ZY) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's April 2021 ini

Monday Deadline for Shareholders to Actively Participate in Zymergen, Inc. (ZY) Class Action: Bronstein, Gewirtz & Grossman, LLC

New York, New York--(Newsfile Corp. - September 30, 2021) -  Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Zymergen Inc. (NASDAQ: ZY).CLICK HERE FOR MORE DETAILS:https://claimyourloss.com/securities/zymergen-inc-loss-submission-form/?id=20010&from=5

ZY Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Zymergen Inc. Shareholders

RADNOR, Pa.--(BUSINESS WIRE)---- $ZY--Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Zymergen Inc. Investors in Securities Fraud Class Action Lawsuit

Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for Zymergen Inc. Investors in Securities Fraud Class Action Lawsuit

New York, New York--(Newsfile Corp. - September 30, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Zymergen Inc. (NASDAQ: ZY).Shareholders who purchased shares of ZY during the class period listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/zymergen-inc-loss-submission-form/?id=20002&from=5

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Zymergen Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 4, 2021 - (ZY)

New York, New York--(Newsfile Corp. - September 30, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased Zymergen Inc. (NASDAQ: ZY) ("Zymergen"). This lawsuit is on behalf of investors who purchased ZY common stock pursuant and/or traceable to the documents issued in connection with the Company's April 2021 initial public offering..If you suffered a loss, contact us at the link below. There is...

ZY LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Zymergen Inc.

San Diego, California--(Newsfile Corp. - September 29, 2021) -  Robbins Geller Rudman & Dowd LLP announces that purchasers of Zymergen Inc. (NASDAQ: ZY) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering ("IPO") have until this upcoming Monday, October 4, 2021 to seek appointment as lead plaintiff. The Zymergen class action lawsuit (Shankar v. Zymergen Inc., No. 21-cv-06028)...

ZY MONDAY DEADLINE: Investors with Substantial Losses Have Opportunity to Lead the Zymergen Inc. Class Action Lawsuit

Boston, Massachusetts--(Newsfile Corp. - September 29, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Zymergen Inc. (NASDAQ: ZY). The case is currently in the lead plaintiff stage. Investors who purchased ZY common stock pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial public offering may contact the Thornton Law Firm's investor protection...

ZY Investor Alert: Shareholder Class Action Lawsuit Filed

SelectQuote

NEW YORK, NY / ACCESSWIRE / September 29, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATVI, ZY and SLQT

San Francisco, California--(Newsfile Corp. - September 29, 2021) -  Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now.Class Period: Apr. 20, 2021 - Aug. 4, 2021Lead Plaintiff Deadline: Oct. 4, 2021Visit: www.hbsslaw.com/investor-fraud/ZY Contact An Attorney Now: ZY@hbsslaw.com 844-916-0895Zymergen Inc. (ZY) Securities Class Action: The case arises from Zymergen's misrepresentations in its Registration Statement for its Apr. 23, 2021, IPO concerning...

ZY INVESTOR DEADLINE: Hagens Berman Encourages Zymergen (ZY) Investors with Losses to Contact Firm's Attorneys BEFORE OCTOBER 4TH DEADLINE in Securities Fraud Lawsuit

Los Angeles, California--(Newsfile Corp. - September 28, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Zymergen Inc. ("Zymergen" or "the Company") (NASDAQ: ZY) for violations of the federal securities laws.Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted in April 2021 (the "IPO"), are encouraged to contact the firm before October 4, 2021. ...

MONDAY DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Zymergen Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

RADNOR, Pa., Sept. 28, 2021 /PRNewswire/ -- September 28, 2021 – The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against Zymergen Inc. (NASDAQ: ZY) ("Zymergen") on behalf of those who purchased or acquired Zymergen common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with Zymergen's April 2021 initial public offering ("IPO").

Zymergen Inc. Class Action Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit

Cassava Sciences Inc

Yalla Group

NEW YORK, NY / ACCESSWIRE / September 27, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court.

LAWSUITS FILED AGAINST ZY, YALA and SAVA - Jakubowitz Law Pursues Shareholders Claims

New York, New York--(Newsfile Corp. - September 27, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) from April 20, 2021 through August 4, 2021 (the "Class Period"). The lawsuit filed in the...

ZYMERGEN INC. (ZY) CLASS ACTION LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Zymergen, Inc.

Philadelphia, Pennsylvania--(Newsfile Corp. - September 27, 2021) - Berger Montague is investigating securities fraud claims against Zymergen Inc. ("Zymergen" or the "Company"). The Firm is investigating these claims on behalf of investors who purchased Zymergen securities (NASDAQ: ZY) on or traceable to the Company's initial public offering (IPO) on April 23, 2021. If you purchased Zymergen securities on or traceable to the IPO and would like to learn more about Berger Montague's investigation, please contact...

Zymergen Inc. Stock: Berger Montague Investigates Securities Fraud Claims Against Zymergen (ZY); Lead Plaintiff Deadline is October 4, 2021

Boston, Massachusetts--(Newsfile Corp. - September 26, 2021) - The Thornton Law Firm alerts investors that a class action lawsuit has been filed on behalf of investors of Zymergen Inc. (NASDAQ: ZY). The case is currently in the lead plaintiff stage. Investors who purchased ZY common stock pursuant or traceable to the registration statement and prospectus issued in connection with the Company's April 2021 initial public offering may contact the Thornton Law Firm's investor protection...

ZY Investor Alert: Shareholder Lawsuit Filed

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Zymergen To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp. - September 26, 2021) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY) and reminds investors of the October 4, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding $50,000 investing in Zymergen stock or options between...

News for Zymergen Stock (ZY)